Drug Shortage Report for KETAMINE HYDROCHLORIDE INJECTION USP

Last updated on 2024-01-30 History
Report ID 179532
Drug Identification Number 02246795
Brand name KETAMINE HYDROCHLORIDE INJECTION USP
Common or Proper name KETAMINE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) KETAMINE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 2ML 10LIVI
ATC code N01AX
ATC description ANESTHETICS, GENERAL
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2023-11-06
Actual start date 2023-11-20
Estimated end date 2023-12-22
Actual end date 2023-12-22
Shortage status Resolved
Updated date 2024-01-30
Company comments Product is available on allocation at wholesalers, based on 100% of historical volumes.
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-01-30 French Compare
v11 2024-01-03 French Compare
v10 2024-01-03 English Compare
v9 2023-11-21 English Compare
v8 2023-11-20 French Compare
v7 2023-11-20 English Compare
v6 2023-11-07 English Compare
v5 2023-09-18 French Compare
v4 2023-09-18 English Compare
v3 2023-02-28 English Compare
v2 2022-12-28 French Compare
v1 2022-12-28 English Compare

Showing 1 to 12 of 12